Molecule to Market Podcast: The stickability factor with Prof. Tom Moody
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tom Moody, Vice President of Technology Development and Commercialisation at Almac.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tom, covering:
- 20 years at Almac and being on a journey that has seen the company go from a few hundred staff to over 5500 people.
- The chemistry of today is not the chemistry of tomorrow, including the future impact of flow chemistry and the need to bring new technologies together.
- The importance of giving back to the community and inspiring the next generation of scientists.
- Reinventing yourself as a way to keep you on your toes
Listen to the full episode here
Almac API, Chemical Development, Analytical & Solid State Services
Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).
We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.
We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.
Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.